Jenny Rooke

San Francisco, California, United States
Jenny Rooke is the Founder and Managing Director of Genoa Ventures. Jenny brings a combination of domain expertise, strategy, and operating and investing experience to her work with early-stage life science companies. She specializes in research tools, diagnostics, and synthetic biology.
Jenny started her venture journey in 2006 at Cambridge, MA-based Fidelity Biosciences (now F-Prime Capital), where she was a Kauffman Fellow. She then carried her investing skills to the Bill & Melinda Gates Foundation, where she was a Senior Program Officer in Global Health Discovery. She played a key role in establishing the foundation’s investing function (Strategic Investment Fund) and managed over $250M in funding in genetic engineering, ag bio, diagnostics, and synthetic biology. Returning to her venture roots in 2013, Jenny began investing under the brand 5 Prime Ventures, financing her investments by launching what became the largest life sciences syndicate on AngelList. In parallel she served as a venture partner with F-Prime Capital and with Anterra Capital, the world’s largest food and agriculture-focused venture firm. Through this work she observed the lack of early-stage capital available to address the growing opportunity set at the convergence of biology and technology and founded Genoa Ventures to fill this gap.
Before her venture career, Jenny held multiple executive positions at U.S. Genomics, a venture-backed biotech startup advancing single molecule detection technologies for diagnostics, biodefense, and research. Previously, Jenny was a management consultant with McKinsey & Co., where she was a business strategist for industry-leading pharmaceutical and biotech companies.
Jenny loves working with teams of brilliant scientists and engineers to transition great ideas and technologies into great products and companies. She earned her Ph.D. in Genetics from Yale University and her B.S. in Physics from Georgia Tech.
Speaking In
4:00 PM - 5:30 PM (EDT)
Monday, September 21
Entrepreneurs and their start-ups keep the bioeconomy vibrant. Meet the 2020 BIO IMPACT Start-Up…
Interactive Online Session